SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis
- 22 March 2022
- journal article
- review article
- Published by Springer Nature in Infection
- Vol. 50 (4) , 849-858
Abstract
Background The COVID-19 pandemic significantly compromised screening, laboratory controls, clinical surveillance and treatment of chronic hepatitis patients and worsened their outcome, as evidenced by its significant correlation with advanced cirrhosis, liver decompensation and mortality. Results This pandemic significantly impaired also the sector of liver transplantation, whose wards, operating rooms, outpatients’ facilities, and healthcare personnel have been dedicated to patients with COVID-19. In addition, screening and treatment for HBV infection have been delayed or suspended in in most countries, with an increased risk of viral reactivation. Similar delay or suspension have also occurred for universal hepatitis B vaccination programs in many countries. Likewise, COVID-19 pandemic has made unreachable the goal of elimination of HCV infection as a worldwide public-health issue predicted for 2030 by the WHO. Conclusion This review article demonstrates how COVID-19 pandemic is causing serious damage to the sector of liver disease, which has quickly lost the beneficial effects of years of study, research, and clinical and technological application, as well as considerable financial investments.Keywords
This publication has 50 references indexed in Scilit:
- Liver injury in COVID-19: management and challengesThe Lancet Gastroenterology & Hepatology, 2020
- COVID‐19 and liver diseaseLiver International, 2020
- Use of Telehealth Expedites Evaluation and Listing of Patients Referred for Liver TransplantationClinical Gastroenterology and Hepatology, 2019
- Telemedicine Based Remote Home Monitoring After Liver TransplantationAnnals of Surgery, 2019
- Telemedicine: An Evolving Field in HepatologyHepatology Communications, 2019
- Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic modelsRespiratory Research, 2018
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceHepatology, 2018
- Neurosurgery and Telemedicine in the United States: Assessment of the Risks and OpportunitiesWorld Neurosurgery, 2016
- Electronic communication with patients. Evaluation of distance medicine technology.1997
- Electronic Communication With PatientsJAMA, 1997